Loading stock data...

Balaxi Pharmaceuticals Limited

NSE: BALAXI

NSE
41.12 -0.82 (-1.96%)

Prev Close

41.94

Open Price

42.1

Volume

55,752

Today Low / High

41 / 42.5

52 WK Low / High

40.76 / 98

Range

39 - 43

Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 41.12, with a change of -0.82 (-1.95517%). The expected target range on the NSE is between 39 - 43. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.

17 Oct 42.10 -2.33%
16 Oct 41.96 -0.05%
15 Oct 42.40 -1.01%
14 Oct 44.09 -3.11%
13 Oct 43.00 1.63%
10 Oct 42.93 1.26%
09 Oct 43.20 -1.00%
08 Oct 42.93 -0.56%
07 Oct 43.67 -0.14%
06 Oct 44.89 -3.85%
03 Oct 44.60 0.65%
01 Oct 43.99 1.23%
30 Sep 42.79 1.99%
29 Sep 43.30 0.55%
26 Sep 44.20 -2.38%
25 Sep 45.00 -2.42%
24 Sep 45.00 -0.09%
23 Sep 47.60 -5.80%
22 Sep 47.71 -1.47%

Balaxi Pharmaceuticals Limited Graph

Balaxi Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Balaxi Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 41.12, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 41.12 41.53 37.38 - 45.68
41.94 33.55 - 50.33
42.35 29.65 - 55.06
Bearish Scenario 41.12 40.71 36.64 - 44.78
40.30 32.24 - 48.36
39.89 27.92 - 51.85

Overview of Balaxi Pharmaceuticals Limited

ISIN

INE618N01014

Industry

Medical - Equipment & Services

Vol.Avg

165,449

Market Cap

457,796,649

Last Dividend

0

Official Website

Visit Website

IPO Date

2015-12-02

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of BALAXI

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2022-07-01 July 01, 22 0.5 0.5 2022-07-04 2022-08-10

Stock Rating Details for BALAXI

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 288.84 Cr 170.53 Cr 126.86 Cr 0.4392 0.00 Cr 44.51 Cr 36.40 Cr 25.07 Cr 4.53 30.56 Cr 0.0868
2024-03-31 241.29 Cr 128.68 Cr 112.61 Cr 0.4667 0.00 Cr 27.79 Cr 46.73 Cr -2.39 Cr -0.46 45.66 Cr -0.0099
2023-03-31 336.43 Cr 202.42 Cr 134.02 Cr 0.3983 0.00 Cr 31.26 Cr 58.63 Cr 45.96 Cr 9.16 60.38 Cr 0.1366
2022-03-31 279.39 Cr 195.60 Cr 83.79 Cr 0.2999 0.00 Cr 13.14 Cr 50.31 Cr 47.66 Cr 9.53 56.02 Cr 0.1706
2021-03-31 231.33 Cr 172.15 Cr 59.19 Cr 0.2558 0.00 Cr 0.58 Cr 42.42 Cr 38.14 Cr 7.63 44.99 Cr 0.1649

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 39.40 Cr 310.34 Cr 78.61 Cr 231.7363 Cr 53.43 Cr 14.03 Cr 0.00 Cr 36.31 Cr 0.00 Cr 0.00 Cr 0.00 Cr 54.5321 Cr
2024-03-31 62.29 Cr 258.34 Cr 56.98 Cr 201.3639 Cr 19.40 Cr -42.89 Cr 82.17 Cr 16.31 Cr 2.88 Cr -2.84 Cr -258.34 Cr 54.1973 Cr
2023-03-31 28.22 Cr 239.67 Cr 56.79 Cr 182.8798 Cr 13.31 Cr -14.91 Cr 105.02 Cr 19.02 Cr 5.06 Cr 56.79 Cr -239.67 Cr 53.1333 Cr
2022-03-31 7.19 Cr 176.47 Cr 63.31 Cr 113.1641 Cr 3.64 Cr -3.55 Cr 98.70 Cr 5.20 Cr 0.00 Cr -2.56 Cr 4.47 Cr 63.2676 Cr
2021-03-31 1.67 Cr 99.68 Cr 34.70 Cr 64.9798 Cr 3.66 Cr 1.99 Cr 13.62 Cr 1.17 Cr 8.85 Cr 0.00 Cr 3.42 Cr 34.6927 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -37.7817 Cr -21.7638 Cr 36.6547 Cr -58.9008 Cr -22.8908 Cr 39.3998 Cr -21.7638 Cr 25.0702 Cr 24.1234 Cr 0.0000 Cr 3.6869 Cr
2024-03-31 4.8661 Cr -1.0463 Cr 30.2539 Cr 3.2967 Cr 34.0738 Cr 62.2906 Cr -0.6926 Cr 2.0153 Cr 6.0402 Cr 0.0000 Cr 22.8553 Cr
2023-03-31 6.0753 Cr -10.5654 Cr 25.5126 Cr -8.9046 Cr 21.0225 Cr 28.2122 Cr -14.9799 Cr 56.9223 Cr 7.9827 Cr -0.4984 Cr -6.3197 Cr
2022-03-31 34.1445 Cr -28.4483 Cr -0.1628 Cr 6.8002 Cr 5.5333 Cr 7.1898 Cr -27.3443 Cr 54.5223 Cr -0.0211 Cr 0.0000 Cr -85.0857 Cr
2021-03-31 0.0031 Cr -5.9728 Cr 3.6461 Cr -2.5532 Cr -2.3235 Cr 1.6565 Cr -2.5564 Cr 44.3293 Cr 3.6592 Cr 0.0000 Cr -12.7858 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 70.74 Cr 39.56 Cr 31.18 Cr 0.4408 3.69 Cr 0.29 Cr 0.05 2.37 Cr 0.0041
2025-03-31 76.27 Cr 39.80 Cr 36.47 Cr 0.4782 9.66 Cr 8.64 Cr 1.56 10.12 Cr 0.1133
2024-12-31 73.29 Cr 43.84 Cr 29.45 Cr 0.4019 3.51 Cr 5.36 Cr 0.97 7.93 Cr 0.0732
2024-09-30 73.27 Cr 44.17 Cr 28.19 Cr 0.3847 5.56 Cr 4.59 Cr 0.83 6.03 Cr 0.0626
2024-06-30 65.62 Cr 38.14 Cr 27.48 Cr 0.4188 10.09 Cr 6.48 Cr 1.17 6.49 Cr 0.0988

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 40.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -231.74 Cr
2025-03-31 39.40 Cr 1.30 Cr 39.40 Cr 110.80 Cr 0.00 Cr 242.77 Cr 36.31 Cr 310.34 Cr 78.61 Cr
2024-12-31 0.00 Cr 0.00 Cr 60.87 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -215.87 Cr
2024-09-30 60.87 Cr 0.00 Cr 60.87 Cr 84.57 Cr 0.00 Cr 239.22 Cr 16.95 Cr 287.97 Cr 72.10 Cr
2024-06-30 -62.57 Cr 125.14 Cr 62.57 Cr 0.00 Cr 0.00 Cr 62.57 Cr 0.00 Cr 0.00 Cr -201.36 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.29 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 8.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 5.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 4.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 6.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2024-05-30 May 30, 24 5:1

Similar Stocks: Medical - Equipment & Services

No stocks found in this industry.

Key Executives

No executive data available.

FAQs about Balaxi Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Ashish Maheshwari.

What is the current market price of the stock?

The current price is ₹41.12.

What is the 52-week price range?

The range is ₹40.76-98.

What is the market capitalization of the company?

The market capitalization is ₹45.78 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 12.64.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Balaxi Pharmaceuticals Limited (ISIN: INE618N01014) is a leading Medical - Equipment & Services in India. With a market capitalization of ₹45.78 crores and an average daily volume of 165,449 shares, it operates in the Medical - Equipment & Services. The company last declared a dividend of ₹0.